Evidence map›Paper›PMID 28411882›Full record

ArticleBiomedical journal2017

In-vitro generation of interleukin-10 secreting B-regulatory cells from donor adipose tissue derived mesenchymal stem cells and recipient peripheral blood mononuclear cells for potential cell therapy.

Kunal S Gupte, Aruna V Vanikar, Hargovind L Trivedi, Chetan N Patel, Jignesh V Patel

Open access · goldAbstract read
In one paragraph

Article in Biomedical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kunal S GupteTransplant Biology Research Lab, Department of Cell Therapy and Regenerative Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India.
Aruna V VanikarTransplant Biology Research Lab, Department of Cell Therapy and Regenerative Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India; Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India. Electronic address: vanikararuna@yahoo.com.
Hargovind L TrivediDepartment of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India; Department of Nephrology and Transplantation Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India.
Chetan N PatelTransplant Biology Research Lab, Department of Cell Therapy and Regenerative Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India; Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India.
Jignesh V PatelTransplant Biology Research Lab, Department of Cell Therapy and Regenerative Medicine, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India; Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, G. R. Doshi and K. M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H. L. Trivedi Institute of Transplantation Sciences (ITS), India.
Institute of Transplantation Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterleukin-10 secreting B-cells are a major subset of B-regulatory cells (B-regs), commonly recognized as CD19 MATERIAL AND

methodsMononuclear cells separated by density gradient centrifugation from 50 ml anti-coagulated blood of 15-RAR and respective donors were analysed for baseline B-regs using appropriate antibodies. Equal amount (20 × 10

resultsIn-vitro generated B-reg count increased to 16.75% from baseline count of 3.35%.

conclusionB-regs can be successfully generated in-vitro from donor AD-MSC and RAR PBMC for potential cell therapy.

Indexed as

Adipose TissueB-LymphocytesCell- and Tissue-Based TherapyHumansImmunomodulationInterleukin-10Leukocytes, MononuclearMesenchymal Stem CellsInterleukin-10Adipose tissue derived mesenchymal stem cellsB-regulatory cellsIL-10ImmunomodulationLipopolysaccharide E. coliPeripheral blood mononuclear cells

Identifiers

PMID28411882
PMCPMC6138595
OpenAlexW2601818077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.